Zou D - Search Results

1

Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt.

Lv F, Deng M, Bai J, Zou D, Wang J, Li H, Zhang Y, Ji X. Lv F, et al. Among authors: zou d. Phytother Res. 2020 Dec;34(12):3345-3358. doi: 10.1002/ptr.6788. Epub 2020 Aug 15. Phytother Res. 2020. PMID: 32798277

2

β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.

Deng M, Liu B, Song H, Yu R, Zou D, Chen Y, Ma Y, Lv F, Xu L, Zhang Z, Lv Q, Yang X, Che X, Qu X, Liu Y, Zhang Y, Hu X. Deng M, et al. Among authors: zou d. Phytomedicine. 2020 Apr;69:153184. doi: 10.1016/j.phymed.2020.153184. Epub 2020 Feb 10. Phytomedicine. 2020. PMID: 32199253

3

Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.

Chen Y, Wu J, Yan H, Cheng Y, Wang Y, Yang Y, Deng M, Che X, Hou K, Qu X, Zou D, Liu Y, Zhang Y, Hu X. Chen Y, et al. Among authors: zou d. Pharmacol Res. 2020 Sep;159:105007. doi: 10.1016/j.phrs.2020.105007. Epub 2020 Jun 17. Pharmacol Res. 2020. PMID: 32561477 Free article.

4

Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway.

Song J, Zou D, Zhao X, Chen Y, Lv F, Wang S, Sui D, Han Q, Yang C, Wang X, Liu B, Deng M, Zhang Y. Song J, et al. Among authors: zou d. Carcinogenesis. 2021 Feb 25;42(2):303-314. doi: 10.1093/carcin/bgaa108. Carcinogenesis. 2021. PMID: 33124657

5

Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway.

Zou D, Song J, Deng M, Ma Y, Yang C, Liu J, Wang S, Wen Z, Tang Y, Qu X, Zhang Y. Zou D, et al. FASEB J. 2021 May;35(5):e21601. doi: 10.1096/fj.202002780R. FASEB J. 2021. PMID: 33913201

6

High SYT7 expression is associated with poor prognosis in human non-small cell lung carcinoma.

Han Q, Zou D, Lv F, Wang S, Yang C, Song J, Wen Z, Zhang Y. Han Q, et al. Among authors: zou d. Pathol Res Pract. 2020 Sep;216(9):153101. doi: 10.1016/j.prp.2020.153101. Epub 2020 Jul 15. Pathol Res Pract. 2020. PMID: 32825966

7

Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation.

Zou D, Bai J, Lu E, Yang C, Liu J, Wen Z, Liu X, Jin Z, Xu M, Jiang L, Zhang Y, Zhang Y. Zou D, et al. Front Oncol. 2021 Oct 21;11:745590. doi: 10.3389/fonc.2021.745590. eCollection 2021. Front Oncol. 2021. PMID: 34745968 Free PMC article.

8

Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.

Zou D, Li Z, Lv F, Yang Y, Yang C, Song J, Chen Y, Jin Z, Zhou J, Jiang Y, Ma Y, Jing Z, Tang Y, Zhang Y. Zou D, et al. Front Oncol. 2021 Mar 4;11:592761. doi: 10.3389/fonc.2021.592761. eCollection 2021. Front Oncol. 2021. PMID: 33747912 Free PMC article.

9

MiR-18a-downregulated RORA inhibits the proliferation and tumorigenesis of glioma using the TNF-α-mediated NF-κB signaling pathway.

Jiang Y, Zhou J, Zhao J, Hou D, Zhang H, Li L, Zou D, Hu J, Zhang Y, Jing Z. Jiang Y, et al. Among authors: zou d. EBioMedicine. 2020 Feb;52:102651. doi: 10.1016/j.ebiom.2020.102651. Epub 2020 Feb 12. EBioMedicine. 2020. PMID: 32062354 Free PMC article.

10

Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6/JAK2/STAT3 signaling in glioma.

Zhou J, Jiang Y, Zhao J, Zhang H, Fu J, Luo P, Ma Y, Zou D, Gao H, Hu J, Zhang Y, Jing Z. Zhou J, et al. Among authors: zou d. Cell Oncol (Dordr). 2020 Jun;43(3):461-475. doi: 10.1007/s13402-020-00502-y. Epub 2020 Mar 23. Cell Oncol (Dordr). 2020. PMID: 32207044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,763 results

Search Page

Filters